From: Deep learning-based cancer survival prognosis from RNA-seq data: approaches and evaluations
TCGA Cancers | TCGA Cancer Abbreviations | Total Cases | Censored (Living) Group | Uncensored (Deceased) Group | Number of Genes After Pre-processing | Age | Overall Survival Months | ||
---|---|---|---|---|---|---|---|---|---|
Median | Range | Median | Range | ||||||
Kidney | KIRP | 286 | 242 | 44 | 17,867 | 61.5 | 28–88 | 25.45 | 0.00–194.65 |
Kidney | KIRC | 531 | 357 | 174 | 17,870 | 61 | 26–90 | 38.96 | 0.00–149.05 |
Liver | LIHC | 369 | 239 | 130 | 17,963 | 61 | 16–90 | 19.32 | 0.00–120.73 |
Breast | BRCA | 1083 | 933 | 150 | 18,030 | 58 | 26–90 | 27.56 | 0.00–282.69 |
Cervical | CESC | 302 | 231 | 71 | 17,731 | 46 | 20–88 | 20.93 | 0.00–210.51 |
Lung | LUAD | 495 | 315 | 180 | 17,715 | 66 | 38–88 | 21.55 | 0.00–238.11 |
Bladder | BLCA | 402 | 225 | 177 | 18,008 | 69 | 34–90 | 17.61 | 0.43–165.90 |
Head-Neck | HNSC | 514 | 296 | 218 | 17,968 | 61 | 19–90 | 21.46 | 0.07–210.81 |
Pancreatic | PAAD | 176 | 83 | 93 | 17,150 | 65 | 35–88 | 15.20 | 0.00–90.05 |
Ovarian | OV | 299 | 119 | 180 | 17,635 | 58 | 30–87 | 31.27 | 0.30–180.06 |
Stomach | STAD | 397 | 244 | 153 | 18,172 | 67 | 30–90 | 14.03 | 0.00–122.21 |
Lung | LUSC | 489 | 283 | 206 | 18,030 | 68 | 39–90 | 21.91 | 0.00–173.69 |